As the aging population grows, a need increases for NPs to screen for common geriatric syndromes during routine primary care ...

Prepregnancy obesity was associated with increased risk for preeclampsia and eclampsia, but the magnitude of this risk varies significantly across racial and ethnic groups.

Tight control of disease activity and reduced glucocorticoid use delay the loss of muscle mass in women with rheumatoid arthritis.

Millions of people are breathing dangerous air this week as heavy smoke from wildfires in Canada and Minnesota spreads across the region.

Fluorescein angiography may help evaluate retinal ischemia in long-standing type 2 diabetes and proliferative diabetic retinopathy.

Higher levels of interleukin (IL)-6 are associated with risk for 9 cardiovascular (CV) and mortality outcomes.

Rates of gestational and type 2 diabetes have increased alongside severe maternal morbidity during US delivery hospitalizations.

The ACC has issued a 2026 scientific statement on the use of direct oral anticoagulants (DOACs) for the prevention of thrombotic events.

Perimenopause uncertainty is prevalent among 34 percent of women aged 35 years or older, according to a study.

Sleeve gastrectomy may offer greater weight loss and glycemic control than semaglutide or tirzepatide in adults with obesity and T2D.

The ACC has released a 2026 scientific statement addressing antiplatelet therapy in atherosclerotic cardiovascular disease (ASCVD).

The FDA has accepted Camurus' resubmitted NDA for CAM2029 (octreotide) extended-release injection for acromegaly, setting a PDUFA date of December 18, 2026.